[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE602005018250D1 - Pkp3-onkogen als prognostischer indikator für lungenadenokarzinom - Google Patents

Pkp3-onkogen als prognostischer indikator für lungenadenokarzinom

Info

Publication number
DE602005018250D1
DE602005018250D1 DE602005018250T DE602005018250T DE602005018250D1 DE 602005018250 D1 DE602005018250 D1 DE 602005018250D1 DE 602005018250 T DE602005018250 T DE 602005018250T DE 602005018250 T DE602005018250 T DE 602005018250T DE 602005018250 D1 DE602005018250 D1 DE 602005018250D1
Authority
DE
Germany
Prior art keywords
pkp3
oncogen
lung adenocarcinoma
prognostic indicator
prognostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005018250T
Other languages
English (en)
Inventor
Yusuke Nakamura
Yataro Daigo
Shuichi Nakatsuru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of DE602005018250D1 publication Critical patent/DE602005018250D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602005018250T 2004-10-19 2005-10-18 Pkp3-onkogen als prognostischer indikator für lungenadenokarzinom Active DE602005018250D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62040504P 2004-10-19 2004-10-19
PCT/JP2005/019458 WO2006043692A1 (en) 2004-10-19 2005-10-18 Pkp3 oncogene as a prognostic indicator for lung cancer

Publications (1)

Publication Number Publication Date
DE602005018250D1 true DE602005018250D1 (de) 2010-01-21

Family

ID=35840452

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005018250T Active DE602005018250D1 (de) 2004-10-19 2005-10-18 Pkp3-onkogen als prognostischer indikator für lungenadenokarzinom

Country Status (6)

Country Link
US (1) US8034578B2 (de)
EP (1) EP1812796B1 (de)
JP (1) JP4908401B2 (de)
AT (1) ATE451619T1 (de)
DE (1) DE602005018250D1 (de)
WO (1) WO2006043692A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112129938B (zh) * 2019-06-25 2023-08-18 中国科学院分子细胞科学卓越创新中心 UDP-Glc在肺癌转移评估中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000066619A2 (en) * 1999-04-30 2000-11-09 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Means and methods for altering the functional properties in eukaryotic cells
EP1463928A2 (de) * 2001-04-18 2004-10-06 Protein Design Labs Diagnoseverfahren für lungenkrebs, zusammensetzungen und verfahren zum screening auf lungenkrebs-modulatoren
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
WO2005089735A2 (en) * 2004-03-24 2005-09-29 Oncotherapy Science, Inc. Compositions and methods for treating lung cancer

Also Published As

Publication number Publication date
JP4908401B2 (ja) 2012-04-04
US8034578B2 (en) 2011-10-11
US20080254452A1 (en) 2008-10-16
ATE451619T1 (de) 2009-12-15
WO2006043692A1 (en) 2006-04-27
EP1812796B1 (de) 2009-12-09
EP1812796A1 (de) 2007-08-01
JP2008516583A (ja) 2008-05-22

Similar Documents

Publication Publication Date Title
DE602004008889D1 (en) Serum macrophage migration inhibitory factor (mif) als marker für prostata krebs
EP1492440A4 (de) Neues verfahren für die diagnose und prognose von malignen erkrankungen
WO2008008500A3 (en) Methods for making cancer prognoses based on the subcellular localization of biomarkers
WO2018187496A8 (en) PLASMA PROTEIN PROFILING FOR THE EARLY PROGNOSIS OF LUNG CANCER
TW200600785A (en) Method for diagnosing non-small cell lung cancer
WO2008030845A3 (en) Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis
IN2013CN01129A (de)
WO2007095644A3 (en) Reagents and methods for cancer prognosis and pathological staging
DE60226271D1 (de) Verfahren zum nachweis von prostatakrebs
NZ597363A (en) Prognosis prediction for colorectal cancer
MX340453B (es) Biomarcadores para cancer de pulmon.
WO2012061759A3 (en) Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
TWI317811B (de)
GB2531881A (en) Method of isolating circulating tumor cells
WO2007035690A3 (en) Methods for diagnosing pancreatic cancer
EP4083233A3 (de) Verfahren zur verwendung von genexpression zur bestimmung der prognose von prostatakrebs
MY150234A (en) Predictive markers for ovarian cancer
NZ594003A (en) Cancer biomarkers
WO2008097908A3 (en) Methods of diagnosing and prognosing lung cancer
WO2008094678A3 (en) A molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof
EA201370063A1 (ru) Фосфолипидом рака
BRPI0606685A2 (pt) anticorpos gitr para o diagnóstico de nsclc
SG165370A1 (en) Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites
WO2009055823A3 (en) Method to predict responsiveness of breast cancer to polyaminetype chemotherapy
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma

Legal Events

Date Code Title Description
8364 No opposition during term of opposition